TdT-positive high-grade B-cell lymphoma with BCOR and IDH1 mutations.

[1]  A. Rosenwald,et al.  The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms , 2022, Leukemia.

[2]  L. Staudt,et al.  The International Consensus Classification of Mature Lymphoid Neoplasms: A Report from the Clinical Advisory Committee. , 2022, Blood.

[3]  L. Medeiros,et al.  Blastoid high-grade B-cell lymphoma initially presenting in bone marrow: a diagnostic challenge , 2021, Modern Pathology.

[4]  S. Swerdlow,et al.  Mutational Landscape of TdT+ Large B-cell Lymphomas Supports Their Distinction From B-lymphoblastic Neoplasms , 2021, The American journal of surgical pathology.

[5]  B. Falini,et al.  BCOR gene alterations in hematological diseases. , 2021, Blood.

[6]  E. Jabbour,et al.  High-grade B-cell lymphomas with TdT expression: a diagnostic and classification dilemma , 2018, Modern Pathology.

[7]  Christophe Béroud,et al.  Exome sequencing identifies recurrent BCOR alterations and the absence of KLF2, TNFAIP3 and MYD88 mutations in splenic diffuse red pulp small B-cell lymphoma , 2017, Haematologica.

[8]  O. Elemento,et al.  EZH2 and BCL6 Cooperate to Assemble CBX8-BCOR Complex to Repress Bivalent Promoters, Mediate Germinal Center Formation and Lymphomagenesis. , 2016, Cancer cell.

[9]  Z. Sachs,et al.  Double- and triple-hit lymphomas can present with features suggestive of immaturity, including TdT expression, and create diagnostic challenges , 2016, Leukemia & lymphoma.

[10]  Yong-Gang Yao,et al.  IDH1 and IDH2 mutations are frequent in Chinese patients with acute myeloid leukemia but rare in other types of hematological disorders. , 2010, Biochemical and biophysical research communications.

[11]  N. Yoo,et al.  Mutational analysis of IDH1 codon 132 in non-Hodgkin lymphomas. , 2010, Leukemia research.